Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1998
05/12/1998US5750499 Antitumor
05/12/1998US5750496 Method of controlling cryptosporidium infectons using protease inhibitors
05/12/1998US5750495 Administering tumor necrosis factor
05/12/1998US5750493 Alpha-1-acid glycoprotein binders
05/12/1998US5750398 Vector, element and method for inhibiting immune recognition
05/12/1998US5750356 Method for monitoring T cell reactivity
05/12/1998US5750351 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
05/12/1998US5750176 Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
05/12/1998US5750147 Fungicides for oral administration
05/12/1998US5750146 Translucent collagen formulations with a cytotoxic drug
05/12/1998US5750140 Transdermal delivery of tiagabine
05/12/1998US5750139 Contained in inner space between impermeable top layer and microporous membrane welded togather
05/12/1998US5750137 Drug delivery, permeability, glycerides and lactates
05/12/1998US5750132 Adinistering extracellular, recombinant hemoglobin to treat disorders resulting from radiation, anemia, tissue ischemia
05/12/1998US5750131 Ifosfamide lyophilizate preparations
05/12/1998US5750125 Containing dibenzyl monosorbitol acetal and a refractory material
05/12/1998US5750122 Compositions for treating hair or skin
05/12/1998US5750091 Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
05/12/1998US5750088 Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
05/12/1998CA2030718C Tricyclic compounds
05/12/1998CA2016951C Method for preparation of taxol
05/12/1998CA2004861C Dermal uses of non-irritating retinoids
05/12/1998CA2001568C Medicament for treating toxoplasmosis
05/12/1998CA1339860C Derivatives of penem
05/08/1998CA2220996A1 New aminomethyl heterocyclic derivatives, their preparation process and the pharmaceutical compositions they contain
05/08/1998CA2218924A1 New sunscreens, photoprotective cosmetic formulations which contain them and uses
05/07/1998WO1998019311A1 Electrically conductive adhesive hydrogels
05/07/1998WO1998018951A1 Receptor-mediated gene transfer system for targeting tumor gene therapy
05/07/1998WO1998018917A2 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE)
05/07/1998WO1998018827A1 Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
05/07/1998WO1998018825A1 Anti-p53 single-chain antibody fragments and their uses
05/07/1998WO1998018812A1 Oligomers which inhibit the expression of interleukin genes
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018807A1 Erythromycin a derivatives
05/07/1998WO1998018803A1 Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof
05/07/1998WO1998018800A1 Stabilized carbapenem antibiotic compositions and method of making
05/07/1998WO1998018798A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
05/07/1998WO1998018797A1 2-methoxyphenylpiperazine derivatives
05/07/1998WO1998018796A1 Naphthyridine derivatives
05/07/1998WO1998018794A1 Novel heterocyclic amide compounds and medicinal uses thereof
05/07/1998WO1998018793A1 Benzoxazole derivative with an affinity to binding sites of amino acid receptors
05/07/1998WO1998018792A1 THIENYLCYCLOHEXANONE DERIVATIVES AS LIGANDS OF THE GABAA α5 RECEPTOR SUBTYPE
05/07/1998WO1998018788A1 Piperazino derivatives as neurokinin antagonists
05/07/1998WO1998018786A1 Constrained somatostatin agonists and antagonists
05/07/1998WO1998018785A1 Substituted oximes derivatives useful as neurokinin antagonists
05/07/1998WO1998018782A1 2-pyrimidineamine derivatives and processes for their preparation
05/07/1998WO1998018779A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018778A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018777A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018776A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018775A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018774A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018773A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
05/07/1998WO1998018771A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018769A1 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake
05/07/1998WO1998018763A1 Tetrahydroisoquinoline derivatives
05/07/1998WO1998018761A1 Substituted arylalkylamines as neurokinin antagonists
05/07/1998WO1998018759A1 Vitamin d analogues
05/07/1998WO1998018758A1 Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof
05/07/1998WO1998018757A1 Synthesis of benzo[f]quinolinones
05/07/1998WO1998018500A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018493A2 Conjugates useful in the treatment of prostate cancer
05/07/1998WO1998018485A1 The use of calpain inhibitors to treat ocular neural pathology
05/07/1998WO1998018481A1 Combination therapy for the treatment of diabetes and obesity
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018479A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract
05/07/1998WO1998018477A2 Pharmaceutical compositions containing lamivudine and zidovudine
05/07/1998WO1998018476A1 Methods of treating or preventing cardiac arrhythmia
05/07/1998WO1998018475A1 Methods of treating or preventing cardiac arrhythmia
05/07/1998WO1998018474A1 Use of ursodeoxycholic acid for the topical treatment of inflammatory diseases of the mucous membranes
05/07/1998WO1998018473A1 Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase
05/07/1998WO1998018472A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
05/07/1998WO1998018471A1 Drugs for ameliorating ocular circulatory disorders
05/07/1998WO1998018470A1 Composition, for the treatment of asthma, containing loratadine and a decongestant
05/07/1998WO1998018468A1 Synergistic composition comprising rapamycin and calcitriol
05/07/1998WO1998018467A1 Compositions for the treatment of renal failure, comprising l-carnosine
05/07/1998WO1998018466A2 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
05/07/1998WO1998018465A1 Use of antagonists of substance p for treating tardive diskinesia
05/07/1998WO1998018464A1 Substituted tricyclics
05/07/1998WO1998018462A1 Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives
05/07/1998WO1998018461A1 Integrin antagonists
05/07/1998WO1998018460A1 Integrin antagonists
05/07/1998WO1998018459A1 Use of phenylcyclopropylamines to stimulate tear secretion
05/07/1998WO1998018458A1 Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma
05/07/1998WO1998018457A1 Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals
05/07/1998WO1998018455A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
05/07/1998WO1998018450A1 Ionophore-mediated liposome loading of weakly basic drug
05/07/1998WO1998018449A1 Methods of preventing breast cancer
05/07/1998WO1998018440A2 Use of inhibitors of the activity of retinoic acid for treating sensitive skin
05/07/1998WO1998018430A2 P2y receptor antagonists
05/07/1998WO1998018429A2 A method for lowering plasma levels of lipoprotein(a)
05/07/1998WO1998018417A1 Fatty acid esters of lactic acid salts as permeation enhancers
05/07/1998WO1998018416A1 Fatty acid esters of glycolic acid and its salts as permeation enhancers
05/07/1998WO1998018326A1 Compounds, compositions and methods for treating antibiotic-resistant infections
05/07/1998WO1998018325A1 Prophylaxis of breast cancer
05/07/1998WO1998018324A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
05/07/1998WO1998018323A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
05/07/1998WO1998013949A3 Method for adapting a receiver to transmission conditions, and the adequate receiver
05/07/1998WO1998009618A3 Graft survival prolongation with porphyrins
1 ... 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 6667 6668 6669 6670 6671 6672 6673 6674 6675 6676 6677 ... 7860